Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Temozolomide

Myleosuppression: 2 case reports

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Sylvester RK, Steen P, Tate JM, Mehta M, Petrich RJ, Berg A, Kolesar J.Temozolomide-induced severe myelosuppression: Analysis of clinically associated polymorphisms in two patients. Anti-Cancer Drugs 22: 104-110, No. 1, Jan 2011. Available from: URL: http://dx.doi.org/10.1097/cad.0b013e3283407e9f - USA

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Temozolomide. React. Wkly. 1338, 33 (2011). https://doi.org/10.2165/00128415-201113380-00112

    Download citation

    Keywords

    • Platelet Count
    • Herpes Simplex
    • Temozolomide
    • Levofloxacin
    • Herpes Simplex Type